Trial intelligence / Profile preview

Evaluation of Different Antalgic Blocks in Total Knee Prosthesis

NCT07751653Recruiting

Sponsor
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Start
Aug 2026
Primary completion
Feb 2027
Countries
1
01

Overview

Randomised, double-blind trial of levobupivacaine in postoperative pain (3 arms), sponsored by IRCCS Ospedale Galeazzi-Sant'Ambrogio. Primary endpoints: Pain at 3 days, Range of Motion at 3 days and 2 more. Started Aug 2026; status: recruiting.

02

Drugs

levobupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07751653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07751653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call